Colin James Bailey

Affiliations: 
Simon Fraser University, Burnaby, British Columbia, Canada 
Area:
Aquatic Ecology
Google:
"Colin Bailey"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bailey CJ, Gavin JR. (2021) Flash Continuous Glucose Monitoring: A Summary Review of Recent Real-World Evidence. Clinical Diabetes : a Publication of the American Diabetes Association. 39: 64-71
Bhatt DL, Szarek M, Pitt B, et al. (2020) Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease. The New England Journal of Medicine
Flory JH, Hennessy S, Bailey CJ, et al. (2020) Response to Comment on Flory et al. Reports of Lactic Acidosis Attributed to Metformin, 2015-2018. Diabetes Care 2020;43:244-246. Diabetes Care. 43: e159
Bailey CJ. (2020) Metformin in women with type 2 diabetes in pregnancy. The Lancet. Diabetes & Endocrinology. 8: 802-803
Bailey CJ, Moore JW. (2020) Resource pulses increase the diversity of successful competitors in a multi‐species stream fish assemblage Ecosphere. 11
Bailey CJ. (2019) Choosing GLP-1 receptor agonists or SGLT-2 inhibitors by cardiorenal risk. The Lancet. Diabetes & Endocrinology
Bailey CJ. (2019) GIP analogues and the treatment of obesity-diabetes. Peptides. 170202
Flory JH, Hennessy S, Bailey CJ, et al. (2019) Reports of Lactic Acidosis Attributed to Metformin, 2015-2018. Diabetes Care
Cosentino F, Grant PJ, Aboyans V, et al. (2019) 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. European Heart Journal
Bailey CJ, Del Prato S, Wei C, et al. (2019) Durability of Glycemic Control with Dapagliflozin, an SGLT2 Inhibitor, Compared with Saxagliptin, a DPP4 Inhibitor, in Patients with Inadequately Controlled Type 2 Diabetes. Diabetes, Obesity & Metabolism
See more...